Immucell Corp (ICCC) is a publicly traded Healthcare sector company. As of May 21, 2026, ICCC trades at $9.88 with a market cap of $89.65M and a P/E ratio of -140.91. ICCC moved -4.90% today. Year to date, ICCC is +63.31%; over the trailing twelve months it is +78.34%. Its 52-week range spans $3.38 to $10.25. Rallies surfaces ICCC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
How does the Rallies community trade ICCC?
Rallies community data for ICCC shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
te Boekhorst Paul Francis Olivier bought 2.43K (~$13.38K) on Dec 4, 2025.
te Boekhorst Paul Francis Olivier bought 3.60K (~$18.15K) on Dec 3, 2025.
te Boekhorst Paul Francis Olivier bought 2.56K (~$12.79K) on Dec 3, 2025.
ICCC Analyst Consensus
ICCC analyst coverage data. Average price target: $0.00.
Common questions about ICCC
How does the Rallies community trade ICCC?
Rallies community data for ICCC shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for ICCC?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for ICCC when enough community data is available.
Is ICCC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ICCC. It does not provide personalized investment advice.
